Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Chatenoud

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|September 5, 2006
Protection from autoimmunity: immunological indifference versus T-cell mediated suppression?Lucienne Chatenoud
Nature Medicine|June 9, 2006
Weaned from the needleLucienne Chatenoud
International Reviews of Immunology|July 5, 2006
CD3-specific antibodies as promising tools to aim at immune tolerance in the clinicLucienne Chatenoud
Diabetologia|January 7, 2019
A future for CD3 antibodies in immunotherapy of type 1 diabetesLucienne Chatenoud
Nature Biotechnology|September 9, 2016
Precision medicine for autoimmune diseaseLucienne Chatenoud
Endocrinology and Metabolism Clinics of North America|July 3, 2002
The use of monoclonal antibodies to restore self-tolerance in established autoimmunityLucienne Chatenoud
Novartis Foundation Symposium|November 12, 2003
CD3 antibody treatment stimulates the functional capability of regulatory T cellsLucienne Chatenoud
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2010
Natural and induced T CD4+CD25+FOXP3+ regulatory T cellsLucienne Chatenoud
Diabetes|July 25, 2013
Therapeutic targeting of B cells and T cells in autoimmune diabetes: is it a solution?Lucienne Chatenoud
Current Opinion in Organ Transplantation|March 28, 2014
Redirecting the treatment and monitoring of organ transplant patientsLucienne Chatenoud
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|September 5, 2006
Protection from autoimmunity: immunological indifference versus T-cell mediated suppression?Lucienne Chatenoud
Nature Medicine|June 9, 2006
Weaned from the needleLucienne Chatenoud
International Reviews of Immunology|July 5, 2006
CD3-specific antibodies as promising tools to aim at immune tolerance in the clinicLucienne Chatenoud
Diabetologia|January 7, 2019
A future for CD3 antibodies in immunotherapy of type 1 diabetesLucienne Chatenoud
Nature Biotechnology|September 9, 2016
Precision medicine for autoimmune diseaseLucienne Chatenoud
Endocrinology and Metabolism Clinics of North America|July 3, 2002
The use of monoclonal antibodies to restore self-tolerance in established autoimmunityLucienne Chatenoud
Novartis Foundation Symposium|November 12, 2003
CD3 antibody treatment stimulates the functional capability of regulatory T cellsLucienne Chatenoud
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2010
Natural and induced T CD4+CD25+FOXP3+ regulatory T cellsLucienne Chatenoud
Diabetes|July 25, 2013
Therapeutic targeting of B cells and T cells in autoimmune diabetes: is it a solution?Lucienne Chatenoud
Current Opinion in Organ Transplantation|March 28, 2014
Redirecting the treatment and monitoring of organ transplant patientsLucienne Chatenoud
Pageof 14